Endocrinology

Top Story

NHANES: HbA1c associated with mortality risk in older adults

NHANES: HbA1c associated with mortality risk in older adults
February 27, 2017

In older adults, an HbA1c greater than 8% was associated with increased risks for all-cause, cardiovascular and cancer-related deaths, according to an analysis of National Health and Nutrition Examination Survey data.

“Few studies have had sufficient data to assess the association between HbA1c and mortality in an exclusive sample of adults aged 65 years and older with and without diabetes, a population at potentially higher risk of adverse diabetes-related complications,” Priya Palta, PhD, associate professor in the department of epidemiology at the Johns Hopkins School of Public Health, and colleagues wrote. “Largely, data on the benefits and outcomes associated with HbA1c lowering remain heterogeneous, particularly among populations of older adults. Therefore, more studies of the HbA1c–mortality relationship are needed to affirm the current clinical practice recommendations and guidelines related to the care of diabetes for older adults.”

In the Journals Plus

Liraglutide 3 mg effective for reversing prediabetes

February 27, 2017
Treatment with subcutaneous liraglutide 3 mg in adults with prediabetes and overweight or obesity may be effective for reducing the risk for progression to diabetes…
In the Journals

Reminders tied to life, calendar events fail to increase medication adherence

February 27, 2017
Researchers tested medication reminders linked to “fresh-start” dates, defined as life and calendar events indicating the start of new cycles such as a…
In the Journals Plus

Once-weekly teriparatide effective for postmenopausal osteoporosis

February 27, 2017
Once-weekly treatment with teriparatide in women with postmenopausal osteoporosis appears to be effective for increasing bone mineral density at the lumbar spine…
In the Journals Plus

Dapagliflozin lowers all-cause mortality risk in type 2 diabetes

February 27, 2017
The risk for all-cause mortality may be lower in adults with type 2 diabetes who have been treated with the SGLT2 inhibitor dapagliflozin compared with those receiving…
More News Headlines »
CME

Practical Lipidology®: Volume 3, Number 1

This activity is supported by an educational grant from Amgen

The reduction of low-density lipoprotein-cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »
Video
Meeting News Coverage

VIDEO: Researchers encouraged by number needed to treat with abaloparatide

September 22, 2016
More »
Featured
ObesityWeek

ObesityWeek

CME

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Current Issues
View the Current Issues
Advertisement
Advertisement